UY31592A1 - Compuestos de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica - Google Patents
Compuestos de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéuticaInfo
- Publication number
- UY31592A1 UY31592A1 UY31592A UY31592A UY31592A1 UY 31592 A1 UY31592 A1 UY 31592A1 UY 31592 A UY31592 A UY 31592A UY 31592 A UY31592 A UY 31592A UY 31592 A1 UY31592 A1 UY 31592A1
- Authority
- UY
- Uruguay
- Prior art keywords
- piridin
- phenyl
- preparation
- application
- carboxamids
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 abstract 2
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 abstract 2
- 101000785650 Homo sapiens Zinc finger protein 268 Proteins 0.000 abstract 1
- -1 NOT Proteins 0.000 abstract 1
- 101001109694 Rattus norvegicus Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 abstract 1
- 102100026516 Zinc finger protein 268 Human genes 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
COMPUESTOS DE N-FENIL-IMIDAZO[1,2-a]PIRIDIN-2-CARBOXAMIDAS de formula (I) en el estado de vase o de sal de adision a un ácido, en la que los sustituyentes y los índices son segun están especificados en la Memoria descriptiva y en las reveindicaciones. Se divulga los métodos de preparacion, la de los intermediarios y su aplicacion en el tratamiento o prevencion de enfermedades que implican los receptorea nucleares Nurr-1 denominados NR4A2, NOT, TINUR, RNR-1 y HZF3.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0800008A FR2925906B1 (fr) | 2008-01-02 | 2008-01-02 | COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31592A1 true UY31592A1 (es) | 2009-08-03 |
Family
ID=39743816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY31592A UY31592A1 (es) | 2008-01-02 | 2008-12-30 | Compuestos de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20100317620A1 (es) |
| EP (1) | EP2225245B1 (es) |
| JP (1) | JP2011509251A (es) |
| KR (1) | KR20100103544A (es) |
| CN (1) | CN101910175A (es) |
| AR (1) | AR070077A1 (es) |
| AT (1) | ATE529426T1 (es) |
| AU (1) | AU2008353144A1 (es) |
| BR (1) | BRPI0821426A2 (es) |
| CA (1) | CA2710811A1 (es) |
| CL (1) | CL2008003931A1 (es) |
| CO (1) | CO6321242A2 (es) |
| EA (1) | EA201070819A1 (es) |
| FR (1) | FR2925906B1 (es) |
| IL (1) | IL206666A0 (es) |
| MA (1) | MA32036B1 (es) |
| TW (1) | TW200934778A (es) |
| UY (1) | UY31592A1 (es) |
| WO (1) | WO2009115651A2 (es) |
| ZA (1) | ZA201004520B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2925900B1 (fr) * | 2008-01-02 | 2011-03-04 | Sanofi Aventis | DERIVES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| US20150329540A1 (en) | 2012-12-28 | 2015-11-19 | Shin Nippon Biomedical Laboratories, Ltd. | Oct3 activity inhibitor containing imidazopyridine derivative as active component, and oct3 detection agent |
| CN103350373B (zh) * | 2013-06-14 | 2017-10-17 | 肇庆市正海机械设备制造有限公司 | 一种磨刀机及磨刀方法 |
| CN113692276A (zh) * | 2019-02-19 | 2021-11-23 | 加利福尼亚大学董事会 | Nurr1受体调节剂 |
| EP4596548A1 (en) * | 2024-02-05 | 2025-08-06 | Ludwig-Maximilians-Universität | Nurr1 modulators |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2638161B1 (fr) * | 1988-10-24 | 1991-01-11 | Centre Nat Rech Scient | Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
| EP1663953A1 (en) * | 2003-09-24 | 2006-06-07 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| EP1742935B1 (en) * | 2004-04-13 | 2010-02-24 | Icagen, Inc. | Polycyclic pyrazines as potassium ion channel modulators |
| FR2903107B1 (fr) * | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| FR2903108B1 (fr) * | 2006-07-03 | 2008-08-29 | Sanofi Aventis Sa | Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique. |
| FR2925900B1 (fr) * | 2008-01-02 | 2011-03-04 | Sanofi Aventis | DERIVES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
-
2008
- 2008-01-02 FR FR0800008A patent/FR2925906B1/fr not_active Expired - Fee Related
- 2008-12-30 CL CL2008003931A patent/CL2008003931A1/es unknown
- 2008-12-30 UY UY31592A patent/UY31592A1/es not_active Application Discontinuation
- 2008-12-31 KR KR1020107014643A patent/KR20100103544A/ko not_active Withdrawn
- 2008-12-31 AU AU2008353144A patent/AU2008353144A1/en not_active Abandoned
- 2008-12-31 AT AT08873376T patent/ATE529426T1/de not_active IP Right Cessation
- 2008-12-31 WO PCT/FR2008/001839 patent/WO2009115651A2/fr not_active Ceased
- 2008-12-31 CN CN2008801238397A patent/CN101910175A/zh active Pending
- 2008-12-31 AR ARP080105782A patent/AR070077A1/es unknown
- 2008-12-31 BR BRPI0821426-3A patent/BRPI0821426A2/pt not_active IP Right Cessation
- 2008-12-31 EP EP08873376A patent/EP2225245B1/fr active Active
- 2008-12-31 JP JP2010541088A patent/JP2011509251A/ja not_active Withdrawn
- 2008-12-31 CA CA2710811A patent/CA2710811A1/fr not_active Abandoned
- 2008-12-31 TW TW097151690A patent/TW200934778A/zh unknown
- 2008-12-31 EA EA201070819A patent/EA201070819A1/ru unknown
-
2010
- 2010-06-25 ZA ZA2010/04520A patent/ZA201004520B/en unknown
- 2010-06-28 IL IL206666A patent/IL206666A0/en unknown
- 2010-07-01 US US12/828,384 patent/US20100317620A1/en not_active Abandoned
- 2010-07-02 CO CO10080864A patent/CO6321242A2/es not_active Application Discontinuation
- 2010-07-27 MA MA33050A patent/MA32036B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR070077A1 (es) | 2010-03-10 |
| FR2925906B1 (fr) | 2010-08-20 |
| EA201070819A1 (ru) | 2010-12-30 |
| ZA201004520B (en) | 2011-09-28 |
| US20100317620A1 (en) | 2010-12-16 |
| BRPI0821426A2 (pt) | 2015-06-16 |
| WO2009115651A3 (fr) | 2010-02-25 |
| EP2225245B1 (fr) | 2011-10-19 |
| CA2710811A1 (fr) | 2009-09-24 |
| CL2008003931A1 (es) | 2010-01-22 |
| CN101910175A (zh) | 2010-12-08 |
| TW200934778A (en) | 2009-08-16 |
| EP2225245A2 (fr) | 2010-09-08 |
| CO6321242A2 (es) | 2011-09-20 |
| IL206666A0 (en) | 2010-12-30 |
| ATE529426T1 (de) | 2011-11-15 |
| AU2008353144A1 (en) | 2009-09-24 |
| KR20100103544A (ko) | 2010-09-27 |
| WO2009115651A2 (fr) | 2009-09-24 |
| MA32036B1 (fr) | 2011-01-03 |
| JP2011509251A (ja) | 2011-03-24 |
| FR2925906A1 (fr) | 2009-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY31727A (es) | Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica | |
| UY31730A (es) | Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica. | |
| UY31588A1 (es) | Derivados de imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica | |
| UY31728A (es) | Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica | |
| UY31729A (es) | Derivados polisustituidos de 2-heteroaril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapeútica | |
| MX377635B (es) | Inhibidores de 3-haloalilamina sustituidos de ssao y uso de los mismos | |
| SI2041133T1 (sl) | Imidazo (1,2,a)piridin-2-karboksamidni derivati, njihova priprava in njihova uporaba v terapevtiki | |
| UY33616A (es) | Compuestos con estructura de imidazotriazinona | |
| CO2018003969A2 (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona | |
| EA201101243A1 (ru) | 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств | |
| UY33337A (es) | DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS | |
| UY31587A1 (es) | Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica. | |
| NI201800051A (es) | Compuestos de imidazo[4, 5-c]quinolin-2-ona y su uso en eltratamiento de cáncer | |
| ECSP10010112A (es) | Compuestos de tienopirimidina y pirazolopirimidina y su uso como inhibidores de mtor cinasa y pi3 cinasa | |
| CR20120264A (es) | Compuestos | |
| DOP2006000084A (es) | Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos | |
| DOP2013000130A (es) | Compuestos de pirimidinona para uso en el tratamiento de las enfermedades o condiciones mediada por lp - pla2 | |
| CY1109743T1 (el) | Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
| MX372721B (es) | Ánalogos halogenados de agentes antifi-broticos. | |
| UY31592A1 (es) | Compuestos de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica | |
| UY31589A1 (es) | Derivados 6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica | |
| UY29343A1 (es) | Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso. | |
| IN2014DN03197A (es) | ||
| UY31593A1 (es) | Derivados de 2-heteroaroil-imidazo[1,2-a]piridina, su preparacion y su aplicacion en terapéutica | |
| CO6382113A2 (es) | Compuestos quimicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20130118 |